Prepayments, Realkredit Danmark A/S
| To NASDAQ Copenhagen | Executive Board Lersø Parkallé 100 DK-2100 København Ø www.rd.dk Telephone +45 7012 5300 Telefax +45 4514 9622 2 January 2023 |
Company Announcement No 1/2023
Prepayments, Realkredit Danmark A/S
Pursuant to §24 of the Capital Markets Act, Realkredit Danmark A/S hereby publishes prepayments as at Friday 30 December 2022. Please find the data in the attached file.
The information will also be available on www.rd.dk.
Yours sincerely
The Executive Board
Any additional questions should be addressed to Hella Gebhardt Rønnebæk, Chief Analyst, phone +45 4513 2068.
Attachments
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Promising Personalized Approach to Liver Cancer Therapy Made Possible by DNA-based Neoantigen Research Designed at The Wistar Institute30.4.2024 16:18:02 CEST | Press release
Geneos Therapeutics, Wistar, and Collaborators Translate Personalized DNA Vaccine Technology into Clinical Outcome Based on Mistakes Tumors Make PHILADELPHIA, PA, April 30, 2024 (GLOBE NEWSWIRE) -- Hepatocellular carcinoma (HCC), or liver cancer, is an aggressive malignancy with limited treatment options. An immunologically cold cancer — meaning the tumors can effectively hide themselves from the immune system — liver cancer can escape or not respond to first-line treatment options, resulting in a poor prognosis. The results of a new clinical trial published in Nature Medicine show that a novel, personalized neoantigen vaccine therapy demonstrated promising anti-tumor efficacy in patients with liver cancer who failed their original front-line treatment. The foundational biomedical research leading to this important study and important outcome originated from research in the Vaccine & Immunotherapy Center at The Wistar Institute. The clinical trial was directed by the Philadelphia bioth
RÄTTELSE: Cortus Energy offentliggör utfall i företrädesemission30.4.2024 16:13:03 CEST | Pressemelding
Stockholm, den 30 april 2024 PRESSMEDDELANDE EJ FÖR OFFENTLIGGÖRANDE, DISTRIBUTION ELLER PUBLICERING, VARKEN DIREKT ELLER INDIREKT, INOM ELLER TILL USA, AUSTRALIEN, BELARUS, HONGKONG, JAPAN, KANADA, NYA ZEELAND, RYSSLAND, SCHWEIZ, SINGAPORE, SYDAFRIKA, SYDKOREA ELLER I NÅGON ANNAN JURISDIKTION DÄR OFFENTLIGGÖRANDE, DISTRIBUTION ELLER PUBLICERING AV DETTA PRESSMEDDELANDE SKULLE VARA OLAGLIG ELLER KRÄVA YTTERLIGARE REGISTRERINGS- ELLER ANDRA ÅTGÄRDER. Med anledning av en felaktig anmälningssedel från en förvaltare har antalet units tecknade med företrädesrätt, i Cortus Energy AB:s (”Cortus Energy” eller ”Bolaget”) företrädesemission bestående av aktier och teckningsoptioner av serie TO11 och TO12, som beslutades av styrelsen den 29 februari 2024 och som godkändes av extra bolagsstämma den 2 april 2024 (”Företrädesemissionen”) felaktigt rapporterats till ett för lågt antal tidigare under dagen idag den 30 april 2024. Antalet units tecknade med företrädesrätt är 214 463 units högre än vad
Resolutions of Annual Geneal Meeting30.4.2024 15:46:13 CEST | Press release
April 30, 2024 Announcement no. 10 Resolutions of Annual Geneal Meeting COPENHAGEN, DENMARK and BOSTON, MA, USA, April 30, 2024, (GLOBE NEWSWIRE) -- BioPorto A/S (BioPorto or Company) (CPH:BIOPOR), an in vitro diagnostics company focused on empowering the early detection of Acute Kidney Injury (AKI), today held its Annual General Meeting with the following results: ITEM 1 - The Board's report on the Company’s activities during the past year was noted by the Annual General Meeting. ITEM 2 – The annual report was approved by the Annual General Meeting and the result for the financial year 2023 was approved to be carried forward to the next financial year. ITEM 3 - Discharge of liability was granted to the Board of Directors and Executive Management. ITEM 4 – The Company’s Remuneration Report for the financial year 2023 was approved by an advisory vote. ITEM 5 – The Annual General Meeting approved the following remuneration for the members of the Board of Directors for the financial year
Adequate own funds and the internal capital adequacy requirement - Danish Ship Finance A/S30.4.2024 15:32:43 CEST | Press release
Adequate own funds and the internal capital adequacy requirement - Danish Ship Finance A/S Attachment No. 7 Adequate own funds and the internal capital adequacy requirement
XBT Provider AB (Publ) - Change of Name Announcement30.4.2024 15:31:40 CEST | Press release
30 April 2024 CoinShares XBT Provider AB (Publ) LEI: 549300HGWKR2Q5T8GK64 XBT Provider AB (Publ) - Change of Name Announcement Stockholm – 30 April 2024 - XBT Provider AB (Publ) is pleased to announce the changing of name from XBT Provider AB (Publ) to CoinShares XBT Provider AB (Publ) as of 10 April 2024. Old Name New Name XBT Provider AB (Publ) Coinshares XBT Provider AB (Publ) About CoinShares XBT Provider CoinShares XBT Provider AB (Publ) (“CoinShares XBT Provider”), a CoinShares company, is the Swedish-domiciled issuer of the Bitcoin Tracker One (SE0007126024), Bitcoin Tracker Euro (SE0007525332), Ether Tracker One (SE0010296574), Ether Tracker Euro (SE0010296582), series of certificates (collectively, the “Certificates”) which are designed to synthetically track the performance of the price of the relevant underlying crypto-asset, bitcoin or ether, (in Swedish Kronor or Euro, respectively), less a fee component. In 2015, Bitcoin Tracker One became the first bitcoin-referenced sec